Free Account Opening + AMC Free Demat
Loading...

CL Educate Buyback vs Marksans Pharma Buyback

Comparision between CL Educate Buyback and Marksans Pharma Buyback.

Buyback Details

CL Educate Buyback is a Open Market Through Stock Exchange buyback proposed to list at BSE, NSE while Marksans Pharma Buyback is a Open Market Through Stock Exchange proposed to list at BSE, NSE.

  CL Educate Limited Marksans Pharma Ltd
Logo CL Educate Buyback Logo Marksans Pharma Buyback Logo
Type of Buyback Open Market Through Stock Exchange Open Market Through Stock Exchange
Listing At BSE, NSE BSE, NSE
Face Value ₹5 per share ₹1 per share
Buyback Price ₹170 per share ₹60 per share
Issue Size
Issue Size (Amount) ₹10.00 Crores ₹60.00 Crores
Buyback Ratio
Registrar Kfin Technologies Limited Bigshare Services Pvt Ltd
Lead Managers V B Desai Financial Services Limited Sundae Capital Advisors
Necessity of the buyback

The Buyback is being undertaken, inter-alia, for the following reasons:

1. The Buyback will help the Company to return surplus cash to its shareholders holding Equity Shares.

2. The Buyback may help in improving return on equity.

The buyback is being undertaken for the following reasons:

1. The Buyback will help the Company to return surplus cash to its shareholders.

2. The Buyback is generally expected to improve return on equity through the distribution of cash and improve earnings per share by the reduction in the equity base of the Company, thereby leading to a long-term increase in shareholders' value.

Buyback Timetable

CL Educate Buyback and Marksans Pharma Buyback buyback timetable. The investors should have the company's shares in their demat accounts as of the record date. CL Educate Buyback Buyback record date is . Marksans Pharma Buyback Buyback record date is .

  CL Educate Limited Marksans Pharma Ltd
Record Date
Offer Open Date May 27, 2022 Jul 15, 2022
Offer Closure Date Jul 29, 2022 Jan 14, 2023
Last date for receipt of tender forms
Finalisation of buyback
Last Date for settlment of bids
Last Date for extinguishment of shares

Financial Details and Other Relevent Information

Comparison of CL Educate Buyback and Marksans Pharma Buyback financial data. The table below also includes a list of all relevant information like Stock Market Data, Compay Information, Lead Manager and Registrar.

  CL Educate Limited Marksans Pharma Ltd
Financial
Summary of financial Information (Consolidated)
Particulars For the year/period ended (Rs. in Lakhs)
  31-Mar-22 31-Mar-21 31-Mar-20
Total Income 21,616.38 19,190.57 32,398.03
Profit After Tax 1,379.06 -1,260.28 -5,480.91
Net Worth 26,163.49 24,710.89 25,920.40
Reserves and Surplus 24,746.92 23,294.32 24,503.83
Summary of financial Information (Consolidated)
Particulars For the year/period ended (Rs. in Lakhs)
  31-Mar-22 31-Mar-21 31-Mar-20
Total Income 1,53,269.20 1,38,287.61 1,13,453.67
Profit After Tax 18,681.40 23,853.88 12,075.27
Net Worth 1,04,216.44 86,972.58 61,990.88
Reserves and Surplus 99,623.30 82,379.44 57,397.74
Stock price at BSE

Stock price at BSE (in preceding 3 months)

Month High Price Low Price Average Price
Apr-2022 170.30 118.10 147.40
Mar-2022 145.70 113.00 131.16
Feb-2022 137.00 98.55 112.83

Stock price at BSE (in preceding 3 months)

Month High Price Low Price Average Price
Jun-2022 48.10 38.70 44.28
May-2022 53.45 44.50 48.20
Apr-2022 62.35 45.55 55.56
Stock price at NSE

Stock price at NSE (in preceding 3 months)

Month High Price Low Price Average Price
Apr-2022 170.25 118.50 144.33
Mar-2022 146.00 110.00 129.45
Feb-2022 137.95 98.00 116.31

Stock price at NSE (in preceding 3 months)

Month High Price Low Price Average Price
Jun-2022 48.10 38.60 44.15
May-2022 53.50 44.50 48.23
Apr-2022 62.40 45.50 56.03

Comments

Add a public comment...